Breaks Categories: News

TuesdayMar 15, 2022 3:42 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Commencement of DehydraTECH-CBD Epilepsy Research Program

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that the first phase of its epilepsy research program EPIL-A21-1 is beginning this week. According to the update, the DehydraTECH(TM)-CBD test articles needed to commence dosing have already been manufactured and delivered to the third-party laboratory engaged to complete this research program. EPIL-A21-1 will assess the seizure inhibiting activity of DehydraTECH-CBD compared to the world's only FDA-approved CBD-based seizure medication, Epidiolex(R). Lexaria hopes to demonstrate superior performance based on DehydraTECH’s known advanced drug delivery capabilities. Lexaria's seizure program expects to leverage the significant gains in systemic…

Continue Reading

TuesdayMar 15, 2022 12:21 pm

CannabisNewsBreaks – Flora Growth Corp.’s (NASDAQ: FLGC) Announces Receipt of 2022 Export Quota for High-THC Cannabis

Flora Growth’s (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, has received its annual export quote from the Colombian Ministry of Health and Social Protection. The company announced that the quota is for a total of 43,600 kg of high-THC cannabis, an updated quota that allows adequate export of medical cannabis products to meet Flora’s existing and future supply agreements in both bulk dry flower and derivatives. That allotment means Flora can produce and export both high-THC dry flower and cannabis derivative products and start to fulfill its previously announced agreements, including the agreement…

Continue Reading

TuesdayMar 15, 2022 10:54 am

CannabisNewsBreaks – RYAH Group Inc. (CSE: RYAH) Secures Medical Device Registration in New Zealand for Proprietary IoT System

RYAH Group (CSE: RYAH) today announced that its subsidiary, RYAH Medtech Inc., has received a medical device certification in New Zealand for its proprietary Internet of Things (“IoT”) powered medical cannabis inhaler, proprietary cartridges and software application associated with the device (the “RYAH Smart Medical Inhaler System”). This comes in coordination with Medical Kiwi Ltd. as local sponsor for the New Zealand certification. Medical Kiwi is a New Zealand-based leader in R&D, manufacturing, cultivation and distribution of medical cannabis and medical devices. “We are pleased to continue gaining traction with medical device registration around the world and are excited to…

Continue Reading

MondayMar 14, 2022 3:19 pm

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Enters Agreement to Bring Mind Naturals to Hong Kong and Key Global Markets

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, today announced its entry into a distribution agreement with Israel-based DNO Group to distribute the Mind Naturals brand in the Hong Kong region. A leading distributor of global independent brands, DNO Group has over 50,000 points of sale throughout Asia in addition to its broader global reach. Under the agreement, Flora will work with DNO to identify growth opportunities and, using an omnichannel approach including brick-and-mortar retail, e-commerce and wholesale, bring the Mind Naturals brand to market in new territories. The initial focus will be…

Continue Reading

MondayMar 14, 2022 2:50 pm

CannabisNewsBreaks – Advanced Container Technologies Inc. (ACTX) to Share Its Story at the 34th Annual Roth Conference

Advanced Container Technologies (OTC: ACTX) today announced that its key executives will be attending the 34th Annual Roth Conference, which is taking place in Laguna Niguel, California, from March 13-15, 2022. The conference is one of the largest of its type in the nation, focusing on small-cap businesses and featuring company presentations, question-and-answer sessions, and one-on-one meetings. ACTX’s long-term growth strategy focuses on several key inter-related vertical markets that provide unique synergy and opportunities. The company's chief initiative is to revolutionize the direct-to-consumer food delivery (“meal kit”) market. “In 2020, amidst a global pandemic, we were able to make key…

Continue Reading

ThursdayMar 10, 2022 11:44 am

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Acquisition Expected to Provide Significant Growth Acceleration

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, recently acquired JustCBD, a market leader in the consumable cannabinoid market. The acquisition is expected to provide meaningful growth acceleration and deliver human capital to the Flora organization and strengthen its foothold in the U.S. wellness market. In addition, there is significant opportunity to leverage Flora’s economically-advantaged cultivation to support expansion of the JustCBD brand across the global market. Roth served as exclusive financial advisor to JustCBD on the transaction. To view the full press release, visit https://cnw.fm/CYSwg About Flora Growth Corp. Flora is building…

Continue Reading

WednesdayMar 09, 2022 12:33 pm

CannabisNewsBreaks – Advanced Container Technologies Inc. (ACTX) Positioned to Help Meet Needs of New USDA Initiative

Advanced Container Technologies (OTC: ACTX) today announced it is ideally suited to help meet the needs of the new USDA initiative to build a new and more equitable food system. The “Build Back Better Food System Transformation Initiative” is designed to expand access to nutritious food in rural, tribal and other areas that are currently underserved. ACTX can be an integral part of this effort through providing GrowPods — transportable controlled environment farms. The pods enable cultivation to be moved directly into the areas where food is needed. In addition, locating GrowPods nearer to the point of consumption allows food…

Continue Reading

TuesdayMar 08, 2022 3:06 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Receives Award for Oral Nicotine Compound Patent

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has been granted an Australian patent titled “Compositions Infused with Nicotine Compounds and Methods of Use Thereof.” The patent expands Lexaria’s world patent portfolio to 24. According to the announcement, the patent expands the company’s international intellectual property rights to apply its proprietary DehydraTECH(TM) enhancement technology to most oral forms of nicotine delivery, which would include pills, tablets, lozenges, capsules, pouches, gums and sprays. In addition to covering different forms of delivery, the patent also includes an array of nicotine forms, such as free base nicotine, nicotine salts, polymer resins of nicotine…

Continue Reading

TuesdayMar 08, 2022 1:32 pm

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Present at 34th Annual Roth Conference

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, today announced that its president and CEO Eric A. Adams will be presenting at the 34th Annual Roth Conference being held March 13-15, 2022. Adams will host a fireside chat with Scoth Henry, managing director and head of pharmaceuticals research at Roth Capital Partners, on Tuesday, March 15. In addition to the live fireside chat, InMed’s virtual Roth Conference presentation is now available on-demand by visiting https://cnw.fm/ardpa. A webcast will be made available to investors following the event in the investor relations section of…

Continue Reading

TuesdayMar 08, 2022 12:22 pm

CannabisNewsBreaks – RYAH Group Inc. (CSE: RYAH) Secures Approval from Health Canada Recognizing RYAH Smart Medical Inhaler System as Medical Device

RYAH Group (CSE: RYAH) today announced that its subsidiary, RYAH Medtech Inc., has received a Health Canada Medical Device License (“MDL”) for its proprietary Internet of Things (“IoT”) powered medical cannabis inhaler, proprietary cartridges and software application associated with the device (the “RYAH Smart Medical Inhaler System”). According to the update, Health Canada License number 107475 allows RYAH to market its Smart Medical Inhaler System to medical patients in Canada and potentially represents a significant boost to RYAH’s growth strategy. “The approval from Health Canada recognizing the RYAH Smart Inhaler System as a medical device is a major step towards…

Continue Reading